Health
Phase 3 trials show AstraZeneca COVID vaccine has up to 90% efficacy – CIDRAP
The peer-reviewed data mirror unpublished results noted last month by the researchers, with up to 90% protection.
The first full peer-reviewed results of phase 3 trials of the COVID-19 vaccine developed by AstraZeneca and Oxford University show that it is safe and up to 90% effective in preventing infection, supporting regulatory submissions for emergency use.
The interim analysis, published today in The Lancet, identified no severe coronavirus disease or hospitalizations in pooled results from the 11,636 adults vaccinated in the United Kingdom and Brazil. Of the 11,636 adults, 131 (1.1%) had symptomatic COVID-19…
-
Business15 hours agoThink Nvidia stock is expensive? This chart might change your mind.
-
General23 hours agoFormer Ukrainian parliament speaker Andriy Parubiy murdered in Lviv
-
General21 hours agoThree dead after angry mob sets fire to parliament building in Indonesia
-
General21 hours agoIsabelle Kelly hospitalised with suspected broken jaw in Sydney Roosters’ NRLW win